Stocks and Investing
Stocks and Investing
Wed, August 14, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Louise Chen Reiterated (zvra) at Buy on, Aug 14th, 2024
Published on 2024-10-28 13:38:57 - WOPRAI, Louise Chen
Louise Chen of Cantor Fitzgerald, Reiterated "Zevra Therapeutics, Inc." (ZVRA) at Buy on, Aug 14th, 2024.
Louise has made no other calls on ZVRA in the last 4 months.
There is 1 other peer that has a rating on ZVRA. Out of the 1 peers that are also analyzing ZVRA, 0 agree with Louise's Rating of Hold.
This is the rating of the analyst that currently disagrees with Louise
- Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $18 on, Monday, August 5th, 2024
Contributing Sources